Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03699085 · ClinicalTrials.gov registry record · NA

Emergency Department Longitudinal Integrated Care

A NA study, sponsored by University of Washington.

Completed
Registry status
NA
Development phase
40
Enrollment target

NCT03699085: Completed NA study, sponsored by University of Washington.

NCT03699085 is a NA study that has completed, run by University of Washington. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03699085, a NA study, has completed, sponsored by University of Washington.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target

Study Summary

The overarching goal of this investigation is to develop and determine the feasibility of a multi-component intervention adapted from a collaborative care framework initiated in the ED for patients at risk for opioid use disorder. This study will provide important feasibility information for future studies of ED-LINC. The collaborative care intervention (ED-LINC) will be supported by a novel Emergency Departement (ED) health information exchange platform.

Primary Outcome

Percentage of subjects who agree to participate in screening survey prior to determining eligibility status. Potential subjects identified by suspected risky substance use history based on EMR review

Interventions

  • BEHAVIORAL ED-LINC

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2018-12-11
Est. Completion 2019-12-31
Phase NA
University of Washington

1,048 total trials

What the finished NCT03699085 record still lists

NCT03699085 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 1 intervention - of which ED-LINC is the first listed.

NCT03699085 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03699085 about?

NCT03699085 is a clinical study titled "Emergency Department Longitudinal Integrated Care". The overarching goal of this investigation is to develop and determine the feasibility of a multi-component intervention adapted from a collaborative care framework initiated in the ED for patients at risk for opioid use disorder. This study will provide important feasibility information for future ...

What is the current status of trial NCT03699085?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2018-12-11. Estimated completion is 2019-12-31.

What interventions are being tested in trial NCT03699085?

The interventions under investigation include: ED-LINC (BEHAVIORAL).

Who is sponsoring clinical trial NCT03699085?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03699085's enrollment target sits among peer trials

40 1447th of 2000 higher than 465 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03699085, the US trial registry maintained by the National Library of Medicine. NCT03699085 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.